Track artwork

Tamiflu US Press Conference

BMJ talk medicine on April 09, 2014 13:53

Play
0.00 / 32.34
Hide the comments

Stats for this track

This Week Total
Plays 7 9407
Favoritings 1
Downloads 1 84

Uploaded by

  • Report copyright infringement

    In 1 Set

    More tracks by BMJ talk medicine

    How not to miss kawasaki disease

    Risky Business - Kevin Fong - learning too much from aviation?

    Job insecurity is associated with adult asthma in Germany during Europe’s recent economic crisis

    Preventing overdiagnosis - the problems with screening

    Is it better to be a thin smoker or a fat ex-smoker?

    View all

    Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported.

    Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures those findings expose.

    Taking part were:
    Fiona Godlee - BMJ editor in chief
    Carl Heneghan - Director of Oxford University's Centre for Evidence Based Medicine
    Peter Doshi - Assistant Professor of Pharmaceutical Health Services Research
    Elizabeth Loder - The BMJ clinical epidemiology editor
    David Tovey - Editor in chief, Cochrane Library
    Ben Goldacre - Founder of the AllTrials campaign

    Add a new comment

    You need to be logged in to post a comment. If you're already a member, please or sign up for a free account.

    Share to WordPress.com

    If you are using self-hosted WordPress, please use our standard embed code or install the plugin to use shortcodes.
    Add a comment 0 comments at 0.00
      Click to enter a
      comment at
      0.00